iSAM Funds UK Ltd Makes New Investment in Corteva, Inc. $CTVA

iSAM Funds UK Ltd bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,200 shares of the company’s stock, valued at approximately $1,795,000. Corteva accounts for about 1.3% of iSAM Funds UK Ltd’s portfolio, making the stock its 10th largest position.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wellington Management Group LLP grew its stake in Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after acquiring an additional 6,881,875 shares during the period. Rakuten Investment Management Inc. acquired a new position in Corteva during the second quarter worth $9,132,000. Kingsview Wealth Management LLC purchased a new position in Corteva during the second quarter valued at $1,093,000. Arbejdsmarkedets Tillaegspension purchased a new position in Corteva during the fourth quarter valued at $23,679,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Corteva in the second quarter valued at about $544,246,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE CTVA opened at $90.07 on Thursday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The stock’s fifty day moving average is $83.17 and its two-hundred day moving average is $80.86. The firm has a market capitalization of $60.09 billion, a P/E ratio of 59.65, a price-to-earnings-growth ratio of 2.69 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Ratings Changes

A number of analysts have recently commented on CTVA shares. CICC Research boosted their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Mizuho raised their price target on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada reiterated an “overweight” rating on shares of Corteva in a report on Friday, August 28th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. Finally, BNP Paribas Exane raised their target price on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.